Vertex Pharmaceuticals (VRTX 1.39%) is making its biggest bet in years. On Monday, the company agreed to acquire Crinetics ...

Any of these blue chip stocks would be solid long-term picks. One of them, however, is especially underestimated right now.

Shares of Meta Platforms (META +2.59%) were heading lower last month as a slew of concerns mounted for the social media giant ...

SpaceX reached a multi-year deal with Alphabet that will average to $920 million per month, starting in October. SpaceX w ...

Shares of Figma (FIG +4.79%) were taking a dive last month as part of a broader pullback in software stocks amid ongoing fears of AI disruption, especially after Anthropic launche ...

Its acquisition of Cursor demonstrates that it recognizes the importance of creating a robust AI platform -- but it also ...

JPMorgan analyst Chris Schott reiterated his overweight (read: buy) rating on Eli Lilly's stock and boosted his share price ...

Well before market open that day, Palantir reported that it had agreed to an "enterprise expansion agreement" with Mexico's ...

Based on Rivian’s closing price of $20.14 per share on July 6, the offering would raise slightly over $1.5 billion. Here’s ...

According to data from S&P Global Market Intelligence, the stock lost 17% last month. As you can see from the chart below, the stock was heading lower over most of the month. Netflix kicked off the ...

Ives assigned SpaceX an outperform rating and a 12-month price target of $190. This implies roughly 18% upside from where it ...

With about 24.2 billion shares outstanding, Nvidia crosses $5 trillion at a share price of roughly $206. From Monday's close ...